Completed OBSERVATIONAL NCT04130490

The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study

Sponsor: Heidelberg Engineering GmbH

Conditions Cataract Cornea Abnormality Healthy Eye IOL Post-Keratorefractive Surgery

Interventions ANTERION

Updated 11 times since 2019 Last updated: Apr 26, 2024 Started: Oct 11, 2019 Primary completion: Oct 30, 2023 Completion: Dec 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cataract and Cornea Abnormality and is currently completed. Heidelberg Engineering GmbH leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2024 — Jul 2024 [monthly]

Completed

Status: Withheld → Completed
Oct 2023 — May 2024 [monthly]

Withheld
Sep 2022 — Oct 2023 [monthly]

Withheld

▶ Show 6 earlier versions

Jul 2022 — Sep 2022 [monthly]

Withheld
Dec 2021 — Jul 2022 [monthly]

Withheld
Jun 2021 — Dec 2021 [monthly]

Withheld
Jan 2021 — Jun 2021 [monthly]

Withheld
Oct 2020 — Jan 2021 [monthly]

Withheld
Nov 2019 — Oct 2020 [monthly]

Withheld

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heidelberg Engineering GmbH

Data source: Heidelberg Engineering GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States